Amyloid imaging with PET in early Alzheimer disease diagnosis.

Keywords

Medicine, Dementia, Positron emission tomography, Disease, Alzheimer's disease

References

• Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PETMargarita Conde — 2012
• Amyloid imaging in Alzheimer's disease: comparison of Florbetapir and Pittsburgh Compound-B PETVictor Henrique Pereira, Russell G. Congalton — 2012
• Using Pittsburgh Compound B for In Vivo PET Imaging of Fibrillar Amyloid-BetaAnn D. Cohen, Gil D. Rabinovici, Chester A. Mathis — 2012
• Neurodegenerative Diseases: List of contributorsM. Flint Beal, Anthony E. Lang, Albert C. Ludolph — 2005
• Neuropathology of Alzheimer's disease: a critical update.K. A. Jellinger, C. Bancher — 1998
• Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.Brian J. Bacskai, Matthew P. Frosch, Stefanie H. Freeman — 2007
• 11C-PiB PET ABri Imaging in Worster-Drought Syndrome (Familial British Dementia): A Case ReportVictor L. Villemagne, Kerryn E. Pike, Svetlana Pejoska — 2010
• PET: the merging of biology and imaging into molecular imaging.Michael E. Phelps — 2000
• Brain Amyloid ImagingChristopher C. Rowe, Victor L. Villemagne — 2011
• Mild cognitive impairment: transition between aging and Alzheimer's disease.R. C. Petersen — 2000
• Frequency of stages of Alzheimer-related lesions in different age categories.Heiko Braak, Eva Braak — 1997
• Testing the Right Target and the Right Drug at the Right StageReisa A. Sperling, Clifford R. Jack, Paul Aisen — 2011
• PET Amyloid Ligand [11C]PIB Uptake and Cerebrospinal Fluid β-Amyloid in Mild Cognitive ImpairmentJ. Koivunen, Tuula Pirttilä, Nina Kemppainen — 2008
• [11C]PIB in a nondemented populationMark A. Mintun, Gina LaRossa, Yvette I. Sheline — 2006
• A new amyloid β variant favoring oligomerization in Alzheimer's‐type dementiaTakami Tomiyama, Tetsu Nagata, Hiroyuki Shimada — 2008
• Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's diseaseAlexander Drzezga, Timo Grimmer, Gjermund Henriksen — 2008
• Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairmentSteven T. DeKosky, Miloš D. Ikonomović, Scot Styren — 2002
• Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.Leonard Berg, Daniel W. McKeel, J. Philip Miller — 1998
• Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individualsReisa A. Sperling, Keith A. Johnson, P. Murali Doraiswamy — 2012
• Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeuticsColin L. Masters, Roberto Cappai, Kevin J. Barnham — 2006

Cited by

• Imaging tau deposits in vivo: progress in viewing more of the proteopathy picture.Maximilian Ludwig — 2013
• Imaging characteristics and safety of florbetapir (18F) in Japanese healthy volunteers, patients with mild cognitive impairment and patients with Alzheimer’s diseaseChihiro Namiki, Yasushi Takita, Atsushi Iwata — 2015
• Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical UseNoble George, Emily Gean, Ayon Nandi — 2015
• The increased potassium intake improves cognitive performance and attenuates histopathological markers in a model of Alzheimer's disease.Pedro Cisternas, Carolina B. Lindsay, Paulina Salazar — 2015
• Fluorodeoxyglucose PET in Neurology and Psychiatry.Michael Schöll, Andrés Damián, Henry Engler — 2014
• Interneurons, tau and amyloid-β in the piriform cortex in Alzheimer’s diseaseDaniel Saiz‐Sánchez, Carlos de la Rosa‐Prieto, Isabel Úbeda‐Bañón — 2014
• Recommendations from the Italian Interdisciplinary Working Group (AIMN, AIP, SINDEM) for the utilization of amyloid imaging in clinical practiceUgo Paolo Guerra, Flavio Nobili, Alessandro Padovani — 2015
• Amyloid Imaging in Atypical Presentations of Alzheimer’s DiseaseDavid A. Wolk — 2013
• Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications.Silvia Bagnoli, Irene Piaceri, Sandro Sorbi — 2014
• FDG PET and the genetics of dementiaBenedetta Nacmias, Valentina Berti, Irene Piaceri — 2013
• Lipidomics of Alzheimer's disease.David Touboul, Mathieu Gaudin — 2014
• Amyloid burden, neuroinflammation, and links to cognitive decline after ischemic stroke.Alexander Thiel, David F. Cechetto, Wolf‐Dieter Heiss — 2014
• Use of amyloid PET across the spectrum of Alzheimer’s disease: clinical utility and associated ethical issuesAntoine Leuzy, Eduardo R. Zimmer, Kerstin Heurling — 2014
• FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic miceBehrooz H. Yousefi, Boris von Reutern, Daniela Scherübl — 2015
• Age Progression of Neuropathological Markers in the Brain of the Chilean Rodent Octodon degus, a Natural Model of Alzheimer's DiseaseNibaldo C. Inestrosa, Juvenal A. Ríos, Pedro Cisternas — 2015
• The Amyloid Hypothesis: Is There a Role for Anti-amyloid Treatment in Late-Life Depression?Nahla Mahgoub, George S. Alexopoulos — 2016
• ‘From past to future’ – deciphering the molecular basis of Alzheimer's disease through the pages of the Journal of NeurochemistryRoberto Cappai — 2016
• Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future.Manuela Ariza, Hartmuth C. Kolb, Dieder Moechars — 2015
• Discovery of 6-(Fluoro-(18)F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([(18)F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs).Abbas Walji, Eric D. Hostetler, Harold G. Selnick — 2016
• Beta-Amyloid-PET-Bildgebung des GehirnsPhilipp T. Meyer, Alexander Drzezga, Peter Bartenstein — 2016

Related papers

• Pediatric Neuroimaging (Contemporary Neuroimaging, Vol. 1)Ehsan Afshani — 1990
• Predictors of Abnormal Neuroimaging of the Brain in Children With Epilepsy Aged 1 Month to 2 YearsOranee Sanmaneechai, Nasuda Danchaivijitr, Surachai Likasitwattanakul — 2015
• The neuroimaging of sacred valuesÓscar Vilarroya, Joseph Hilferty — 2013
• Neuroimaging of Early Life EpilepsyJason Coryell, William D. Gaillard, Renée A. Shellhaas — 2018
• Incidental Neuroimaging Findings in Nonacute HeadacheW. Graf, Husam Kayyali, Ahmed Abdelmoity — 2010
• Can structural neuroimaging be used to define phenotypes and course of schizophrenia?John G. Kerns, John Lauriello — 2012
• [IM‐05]: Basic principles of amyloid PET imagingMark A. Mintun — 2005